ArticleScientific reports2025
NMR and GC-MS based metabolic profiling, total phenolic content, antibacterial, antioxidant, anticancer and In-silico antiviral activity of Origanum ramonense plant.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Origanum ramonense is a rare and underexplored aromatic (Lamiaceae family) native to the Mediterranean region, but despite its prospects as a medicinal plant, there is a shortage of spectrometry based metabolic profiling of this plant. Thus, the objective of this study was to carry out a detailed investigation of the metabolic profile of Origanum ramonense extracts using multiple solvents (methanol, methanol/water, ethyl acetate, dichloromethane/methanol, and hot water) of varying polarity, and further assess its bioactive potential. Using analytical tools such as NMR and GC/MS, we identified functional groups of plant metabolites and further employed multiple assays such as DPPH (antioxidant activity) and the Folin-Ciocalteu method to understand the plant's bioactivity. The extracts were found to be rich with polyphenolic compounds (17.8-107.2 mg Gallic acid per gram extract) and had strong antioxidant activity (IC50 5.8-128.5). The promising bioactivity was validated not only by results for in-vitro anticancer and (MCF-7 and HeLa cells) antibacterial tests (S. aureus and S. pneumoniae) but also in-silco molecular docking further showed the potential of antiviral activity of the extracted metabolites against SARS-CoV. These findings highlight O. ramonense as a valuable source of natural antioxidants and bioactive compounds, underscoring the need for further research into its medicinal properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.